It’s possible that I shall make an ass of myself. But in that case one can always get out of it with a little dialectic. I have, of course, so worded my proposition as to be right either way (K.Marx, Letter to F.Engels on the Indian Mutiny)
Thursday, June 04, 2026
Toward “vibe medicine”: a self-evolving multi-agent framework for clinical decision support
System architecture of the VIBEMed framework, consisting of the multi-agent collaborative framework, three-level self-evolution mechanism and an architecture-level safety sandbox.
Large language models (LLMs) and AI agents have shown strong potential in medical imaging analysis, diagnosis, and treatment planning. However, most current medical AI systems still rely on pre-trained knowledge and fixed workflows. This limitation hinders their ability to learn from long-term clinical feedback, patient outcomes, or previous treatment experience, making it difficult for them to adapt to the complexity of real-world clinical practice.
To address this challenge, a team led by Dr. Lian Zhang from the First Hospital of Hebei Medical University, proposed the concept of "Vibe Medicine" and developed VIBEMed (Versatile Intelligent Behavior-Evolving Medical framework).
"VIBEMed uses multi-agent collaboration to break complex clinical decisions into three specialist roles: the Clinical Diagnostic Agent (CDA) for diagnostic reasoning and hypothesis generation, the Therapeutic Execution Agent (TEA) for treatment planning, and the Clinical Evolution Manager Agent (CEMA) for integrating longitudinal feedback and driving continuous optimization," shares co-corresponding author Lian Zhang.
Unlike conventional single-model approaches, VIBEMed further implements a three-level self-evolution mechanism spanning memory, model, and code, improving the performance of the backbone LLM and system over time. It also employs an architecture-level safety sandbox to constrain model updates and data access, ensuring that continuous evolution remains safe, controllable, and traceable.
The team then validated VIBEMed in complex clinical scenarios. Compared with traditional single-model pipelines. "The framework demonstrated superior performance in complex medical reasoning and treatment planning tasks," says Zhang. "VIBEMed presents an experience-driven medical AI system with strong adaptive capabilities, offering a practical direction for clinical decision-support systems that can learn continuously and evolve safely."
###
Contact the author: Lian Zhang, the First Hospital of Hebei Medical University, lianzhang@hebmu.edu.cn
The publisher KeAiwas established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).
WashU Medicine researchers genetically modified hookworms to produce and deliver a therapeutic antibody inside a host, a proof-of-concept that could lead to long-lasting treatments for chronic disease or exposure to toxins in remote settings.
Hookworms, intestinal parasites that infect hundreds of millions of people in under-resourced tropical regions around the globe, have evolved to survive inside the human gut for years, secreting molecules that enable co-existence with their hosts. Now, researchers at Washington University School of Medicine in St. Louis have harnessed that biological mechanism for potential human benefit, engineering a hookworm to produce and deliver a drug within a living host.
In a new study, the team reports the first successful genetic modification of the human hookworm. It was designed to produce an antibody that neutralizes tetrodotoxin, a deadly neurotoxin produced by pufferfish and other marine animals. After colonizing an animal host with the modified hookworms, the parasites produced the antitoxin and secreted it into the bloodstream, partially inactivating the toxin.
The findings demonstrate that this drug production and delivery approach could be a long-term solution to any number of medical needs, from chronic conditions requiring continuous drug treatment to exposure to toxins in remote locations without medical care available.
The findings were published June 3 in Nature Communications.
“The hookworm has spent millions of years perfecting how to assure long-term survival inside a human host and how to get molecules out of its body and into ours,” said senior author Makedonka Mitreva, PhD, the Gordon R. Miller Professor in the John T. Milliken Department of Medicine’s Division of Infectious Diseases at WashU Medicine. “We asked: What if we could add one more molecule to the roughly 1,000 things the worm already secretes, something therapeutically useful to people? This study shows that’s not just a concept. It works.”
A parasite that delivers
Hookworms have already been studied as treatments for inflammatory bowel diseases such as ulcerative colitis, based on evidence that the anti-inflammatory molecules the worms secrete can dampen the immune responses that drive those conditions. Mitreva’s team set out to build on that foundation by engineering the worm to secrete a therapeutic of the researchers’ choosing, rather than relying solely on what the parasite produces naturally.
The appeal of hookworms as a long-term drug production and delivery platform stems from a quirk of their biology. When a person is infected with a controlled number of hookworm larvae, which can be administered orally as a pill or through the skin like a lotion, the worms migrate to the small intestine and take up residence, often for years. Because they cannot multiply inside the host, the number of worms stays fixed, and the infection remains controlled. If the infection ever needs to be cleared, a single dose of an oral anti-parasitic drug eliminates the hookworms within 24 hours.
Although natural hookworm infection may cause only mild digestive symptoms in healthy adults, chronic infection with large number of hookworms can be dangerous for children, pregnant people and malnourished or otherwise vulnerable individuals, leading to anemia, poor growth and development, pregnancy complications and, in extreme untreated cases, heart problems or death. This underscores the importance of keeping the infection strictly controlled for therapeutic use, Mitreva noted, which is possible because of the worms’ inability to reproduce without spending part of their life cycle in soil.
The antibody selected for this proof-of-concept study neutralizes tetrodotoxin, a paralyzing and potentially lethal toxin with no antidote. The work was funded by the U.S. government’s Defense Advanced Research Projects Agency, with an eye toward finding solutions to biological and chemical threats to soldiers in remote locations.
The project presented significant technical hurdles: gene-editing tools that work in other organisms had not been adapted for hookworms, and no one had previously achieved stable genetic modification in the species.
To adapt hookworms for therapeutic use, Mitreva and her team drew on more than two decades of hookworm genomics research conducted at WashU Medicine. This depth of data helped them understand the organism’s biology from the cellular to the genetic level, allowing them to locate a viable site in the genome to insert the new gene carrying instructions for making the new antitoxin. Critically, they had to ensure the insertion wouldn’t disrupt surrounding gene activity and would prompt the worm to secrete the antitoxin out into the host.
The effort was successful: Blood collected from hamsters infected with Mitreva’s genetically modified hookworms partially neutralized tetrodotoxin, whereas blood from animals infected with unmodified worms had no neutralizing capability.
From proof-of-concept to broader platform
Mitreva noted that the level of neutralization achieved in this initial study, while significant, likely represents only a fraction of what the platform can ultimately deliver.
Several components of what she calls a “configurable chassis” are still being optimized to increase the amount of therapeutic protein produced and secreted. Because the worm resides in the gut and a substantial portion of what it secretes remains there, rather than entering the bloodstream, the researchers expect that concentrations of therapeutic molecules in the intestine may be substantially higher than what was detected in circulation in this study, making the platform suitable for gut-directed therapies.
“What we demonstrated here is that the concept works end to end — you can insert a gene, the worm produces the protein, the protein gets out of the worm, and it is functionally active in the host,” Mitreva said. “From that starting point, we can optimize the platform and think carefully about which diseases stand to benefit most from a delivery system that is continuous, targeted and long-lasting. That’s a fundamentally different kind of pharmaceutical biofactory platform, and we think it opens possibilities that are very hard to achieve with any other platform.”
Gut inflammatory diseases, including Crohn’s disease and ulcerative colitis, and food allergies are among the conditions Mitreva sees as strong candidates for future development. Diseases requiring small but sustained therapeutic concentrations, where compliance with repeated injections or infusions is a barrier, may also be well-suited to the platform.
Future studies will need to conduct rigorous safety evaluations before human use. Mitreva noted that biocontainment strategies, such as engineering the worms to be unable to produce eggs, are under consideration to protect hosts and their environments as the platform advances.
Singh KS, Bharti S, Rosa BA, Bigham M, Uzoechi SC, Choi YJ, Martin JC, Kemper D, Pavlovic Djuranovic S, Pickering DA, Ryan R, Bracken BK, Bottazzi ME, Carnes E, Ittiprasert W, Moyle M, Brindley PJ, Loukas A, Djuranovic S, Mitreva M. Transgenic hookworm secretes anti-tetrodotoxin human single chain antibody. Nature Communications. June 3, 2026. DOI: 10.1038/s41467-026-73447-9
K.S.S., S.B., B.A.R., M.B., S.C.U., Y.J.C., J.C.M., D.K., S.P.D., D.A.P., R.R., B.K.B., M.E.B., W.I., M.Moyle, P.J.B., A.L., S.D. and M.M. disclose support for the research of this work from the Defense Advanced Research Projects Agency (DARPA) and Naval Information Warfare Center Pacific (NIWC Pacific) [Contract No. N66001-21-C-4013]. E.C.C. discloses support for the research of this work from the Defense Advanced Research Projects Agency (DARPA) [Contract No. N660012314009]. The views, opinions and/or findings expressed are those of the author and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government. Distribution Statement “A” (Approved for Public Release, Distribution Unlimited).
About WashU Medicine
WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 3,100 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 78% since 2016. Together with institutional investment, WashU Medicine commits over $1.6 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently among the top five in the country, with more than 2,550 faculty physicians practicing at 200 locations. WashU Medicine physicians exclusively staff Barnes-Jewish and St. Louis Children’s hospitals — the academic hospitals of BJC HealthCare — and Siteman Cancer Center, a partnership between BJC HealthCare and WashU Medicine and the only National Cancer Institute-designated comprehensive cancer center in Missouri and southern Illinois. WashU Medicine physicians also treat patients at BJC’s community hospitals in our region. With a storied history in MD/PhD training, WashU Medicine recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.
WashU Medicine researchers genetically modified hookworms to produce and deliver a therapeutic antibody inside a host, a proof-of-concept that could lead to long-lasting treatments for chronic disease or exposure to toxins in remote settings.
Credit
Courtesy of Makedonka Mitreva
Article Title
Transgenic hookworm secretes anti-tetrodotoxin human single chain antibody
Article Publication Date
3-Jun-2026
COI Statement
K.S.S., S.B., B.A.R., M.B., S.C.U., Y.J.C., J.C.M., D.K., S.P.D., D.A.P., R.R., B.K.B., M.E.B., W.I., M.Moyle, P.J.B., A.L., S.D. and M.M. disclose support for the research of this work from the Defense Advanced Research Projects Agency (DARPA) and Naval Information Warfare Center Pacific (NIWC Pacific) [Contract No. N66001-21-C-4013]. E.C.C. discloses support for the research of this work from the Defense Advanced Research Projects Agency (DARPA) [Contract No. N660012314009]. The views, opinions and/or findings expressed are those of the author and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government. Distribution Statement “A” (Approved for Public Release, Distribution Unlimited).
Hail conditions on the move as winter crops face rising risk
A hailstorm can undo a season’s work in minutes. It can strike quickly and unevenly, shredding wheat, bruising fruit, flattening crops – while also leaving neighbouring paddocks untouched.
In a new Nature Climate Change study, scientists from UNSW Sydney say the geography and seasonality of that risk is changing.
As the planet warms, the atmospheric conditions that produce damaging hail are projected to shift away from some warmer regions towards the cooler parts of the world – including south-eastern Australia and New Zealand.
Lead author Dr Tim Raupach from the UNSW Institute of Climate Risk and Response says this is part of an overall hail condition frequency shift towards the poles.
“Under modelling scenarios of 2°C and 3°C of global warming, we see this overall shift towards more risk in cooler places and cooler times of the year,” Dr Raupach says.
“So increasing risk in winter and often decreasing risk in summer – a shift from warmer to cooler regions and seasons,” he says. “Those cooler regions include not only parts of southern Australia and New Zealand, but northern North America and Europe.
“And there are decreases – though still with a lot of uncertainty – in the subtropics and parts of the mid-latitudes. This includes much of Australia as well as regions of India, China and much of Africa.”
An atmospheric tug of war
Because hailstorms are brief and difficult to observe, the researchers did not model hailstones directly. Instead, they used three different proxies, or methods, to detect atmospheric conditions that occur when hail is more likely to form.
These proxies did not always agree, particularly in the tropics, underscoring how difficult future hail risk remains to predict. The disagreement showed that with a warmer atmosphere, several forces act at the same time.
“Usually, as the atmosphere gets warmer, we expect it to have more energy, which could be turned into updrafts,” Dr Raupach says. Updrafts are a key feature of hailstorms.
“When you have these strong winds in the thunderstorms, they can support the growth of larger hailstones,” he says.
At the same time, warmer air also raises the level at which frozen hailstones begin to melt.
“There is a lot more melting in a warmer atmosphere,” Dr Raupach says.
“This can make smaller hailstones melt away.”
The result is an offsetting effect, or an atmospheric tug of war, where warming pushes the system in two directions at once.
“The atmosphere might be more prone to create storms, but the storms that are created might be less likely to have hail reach the ground,” Dr Raupach says.
However, he says the concern is that while hail may become less common across some regions or seasons, they may be more destructive when they do happen.
“Larger hailstones are more likely with stronger storm dynamics,” he says. “That still has important implications for agriculture.”
Winter crops in the firing line
A decrease in summer hail risk also does not necessarily help a winter crop if the danger rises during growing season.
The researchers examined 26 major crop types globally.
“One of the things that makes this study unique is that we looked at the changes in risk to crops based on the hazard changes that we see in the hail-prone environments,” Dr Raupach says.
He and the team looked at what proportion of each crop’s growing season was likely to be affected by hail-prone conditions, and how that exposure changed in future climate projections.
“We saw in the future projections that often the hazard was increasing for winter crops.”
In Australia, where wheat is a major winter crop, the signal is clearest in the south-east – from Tasmania up along the broad arc from Melbourne towards Sydney – where hail-prone environment increases appear in both past trends and future projections.
Risk planning
A crop does not even need to be damaged often for hail to matter – just one severe storm is enough. But for farmers, insurers and policymakers, it is a difficult risk to plan around.
The findings also complicate some assumptions about climate adaptation. As global warming forces crop-growing regions to shift poleward, agriculture may also move into areas where hail risk is increasing.
This means that potential gains from a warmer climate, such as new growing zones or longer seasons in cooler regions, could be offset by exposure to more damaging storm conditions.
Dr Raupach says the uncertainty surrounding future hail risk remains a major challenge.
“It’s hard,” he says. “The uncertainty of it and the difficulty in getting at exactly what’s going on is one of the challenges that we face, and that decision-makers face.
“But we can make broad statements. And the shift towards the poles is the broad statement we can make here.”
Dr Joanna Aldridge is the Head of Research & Development, Catastrophes at QBE, which supported the research.
She says this work is building the scientific evidence base needed to understand how hail risk is shifting.
“This enables better risk assessment, resilience planning and decision-making across industries such as insurance and agriculture,” Dr Aldridge says.
On the move
For Australia, another broad statement concerns the south-east of the continent.
“The southeast of Australia comes up not only in the trends that we see in the past, but also in the future projections as a place where the hazard is increasing,” Dr Raupach says.
While hail has often received less public attention than other climate-linked agricultural threats – such as drought, heatwaves, floods and bushfires – for farmers it can be one of the most immediate and damaging hazards.
The study warns these overlapping shifts “may attenuate any positive impact on crop yields in a warming world”.
Dr Tim Raupach’s position at UNSW is supported by QBE Insurance. Dr Raupach and study co-author Professor Steven Sherwood are affiliated with the UNSW Climate Change Research Centre and the ARC Centre of Excellence for 21st Century Weather – where Dr Raupach is an Associate Investigator and Prof. Sherwood is a Chief Investigator.
Shifting hail hazard under global warming and effects on crop hail risk
Article Publication Date
3-Jun-2026
The UJI Altadia Chair in Ceramic Knowledge enhances scientific knowledge and knowledge transfer with the publication of the first volume of the "Encyclopaedia of Ceramic Technology"
Has presented the first volume of the "Encyclopaedia of Ceramic Technology", a work that brings together the scientific foundations underpinning the current manufacture of white ceramic products
Photo: Encarna Blasco Roca, José Luis Amorós Àlbaro and Arnaldo Moreno.
The UJI Altadia Chair in Ceramic Knowledge has presented the first volume of the Enciclopedia sobre Tecnología Cerámica (Encyclopaedia of Ceramic Technology), a work that compiles the scientific foundations underpinning the current manufacture of white ceramic products and provides an in-depth analysis of the processes and behaviour of the materials used in floor and wall tiles, earthenware and porcelain.
This first volume, published by Publicacions de la Universitat Jaume I as part of the “Universitas” collection, has been authored by José Luis Amorós Álbaro, one of Spain’s leading academic and technical experts in ceramic technology, particularly in white ceramics manufacturing processes, together with Encarna Blasco Roca, a highly respected researcher in the field. Both have developed much of their professional careers at the Institute of Ceramic Technology (ITC-AICE) and the Universitat Jaume I, combining research, teaching and technology transfer within the ceramic tile industry.
The presentation took place at the Institute of Ceramic Technology (ITC), coinciding with the third anniversary of the creation of the Chair. The event featured the participation of the authors, accompanied by David Cabedo, Vice-Rector for Innovation, Knowledge Transfer and Science Communication at the Universitat Jaume I; Antonio Blasco, Board Member of the Altadia Group; and Arnaldo Moreno, Director of the UJI Altadia Chair in Ceramic Knowledge and Professor of Chemical Engineering.
Entitled Fundamentos del proceso de fabricación de materiales de cerámica blanca (Fundamentals of the Manufacturing Process of White Ceramic Materials), the publication provides an updated synthesis of the scientific and technological foundations of the processing of these materials. The work organises existing knowledge in the field and serves as a valuable resource for understanding product design, process development and quality improvement in the ceramic industry.
Beyond its academic and technological significance, the publication highlights the strong scientific foundations on which Castelló’s ceramic industry is built, its high added value and its contribution to innovation and sustainability within the sector, factors that directly enhance the competitiveness of the region’s industrial fabric.
About the Enciclopedia sobre Tecnología Cerámica
The encyclopaedia was conceived as a multi-volume publication dedicated to the scientific foundations that support the modern manufacture of white ceramic products, with the aim of providing a scientific interpretation of the phenomena involved in their processing.
The first chapter of this volume analyses and rationally describes ceramic processing, based on both the understanding of the relationship between material properties and their microstructural characteristics and the response of the material at each stage of the process—that is, how its microstructural features change when operating variables are modified.
Subsequent chapters examine the laws and principles governing the physical processes and chemical reactions that influence the microstructural changes experienced by materials throughout the different stages of manufacture. In this regard, the volume addresses phenomena such as colloidal behaviour, surface and interparticle forces, and suspension stabilisation mechanisms, all of which are fundamental to obtaining stable ceramic suspensions.
The UJI Altadia Chair in Ceramic Knowledge has presented the first volume of the Enciclopedia sobre Tecnología Cerámica (Encyclopaedia of Ceramic Technology), a work that compiles the scientific foundations underpinning the current manufacture of white ceramic products and provides an in-depth analysis of the processes and behaviour of the materials used in floor and wall tiles, earthenware and porcelain.
This first volume, published by Publicacions de la Universitat Jaume I as part of the “Universitas” collection, has been authored by José Luis Amorós Álbaro, one of Spain’s leading academic and technical experts in ceramic technology, particularly in white ceramics manufacturing processes, together with Encarna Blasco Roca, a highly respected researcher in the field. Both have developed much of their professional careers at the Institute of Ceramic Technology (ITC-AICE) and the Universitat Jaume I, combining research, teaching and technology transfer within the ceramic tile industry.
The presentation took place at the Institute of Ceramic Technology (ITC), coinciding with the third anniversary of the creation of the Chair. The event featured the participation of the authors, accompanied by David Cabedo, Vice-Rector for Innovation, Knowledge Transfer and Science Communication at the Universitat Jaume I; Antonio Blasco, Board Member of the Altadia Group; and Arnaldo Moreno, Director of the UJI Altadia Chair in Ceramic Knowledge and Professor of Chemical Engineering.
Entitled Fundamentos del proceso de fabricación de materiales de cerámica blanca (Fundamentals of the Manufacturing Process of White Ceramic Materials), the publication provides an updated synthesis of the scientific and technological foundations of the processing of these materials. The work organises existing knowledge in the field and serves as a valuable resource for understanding product design, process development and quality improvement in the ceramic industry.
Beyond its academic and technological significance, the publication highlights the strong scientific foundations on which Castelló’s ceramic industry is built, its high added value and its contribution to innovation and sustainability within the sector, factors that directly enhance the competitiveness of the region’s industrial fabric.
The publication of this first volume represents the fulfilment of one of the strategic projects announced in 2023 with the creation of the UJI Altadia Chair in Ceramic Knowledge, an initiative promoted by the Altadia Group to strengthen scientific knowledge and facilitate the transfer of new advances and innovations in the sector.
About the Enciclopedia sobre Tecnología Cerámica
The encyclopaedia was conceived as a multi-volume publication dedicated to the scientific foundations that support the modern manufacture of white ceramic products, with the aim of providing a scientific interpretation of the phenomena involved in their processing.
The first chapter of this volume analyses and rationally describes ceramic processing, based on both the understanding of the relationship between material properties and their microstructural characteristics and the response of the material at each stage of the process—that is, how its microstructural features change when operating variables are modified.
Subsequent chapters examine the laws and principles governing the physical processes and chemical reactions that influence the microstructural changes experienced by materials throughout the different stages of manufacture. In this regard, the volume addresses phenomena such as colloidal behaviour, surface and interparticle forces, and suspension stabilisation mechanisms, all of which are fundamental to obtaining stable ceramic suspensions.
UJI Altadia Chair in Ceramic Knowledge
The UJI Altadia Chair in Ceramic Knowledge was established in February 2023 through a collaboration between the Universitat Jaume I and the Altadia Group. Its purpose is to preserve and disseminate the knowledge accumulated over the past forty years, during which the sector has undergone major technological transformations and to which researchers and professionals have contributed through concepts, evidence, experiments, process improvements, materials knowledge and new technologies.
This partnership between academia and industry has already produced its first major outcome with the publication of this volume, reinforcing the shared commitment to research, innovation and knowledge transfer to the ceramic sector.
Scientists map the microbes behind a climate-regulating gas in India's busiest estuary — a first
Bentham Science Publishers
Article by Dibu Divakaran / Dr. Doniya Elze Mathew Department of Chemical Oceanography, Cochin University of Science and Technology (CUSAT), Kochi, Kerala, India E-mail: dibudk@gmail.com / doniyaelze@gmail.com
Why This Estuary Matters to the Global Sulfur Cycle
Every year, marine plants — from microscopic phytoplankton to seaweeds — produce vast quantities of a sulfur compound called dimethylsulfoniopropionate, or DMSP. When bacteria in the water and sediment break DMSP down, they release dimethylsulfide (DMS), a gas that drifts into the atmosphere and helps form clouds by seeding cloud condensation nuclei — making it one of the most climate-relevant gases produced by ocean life. Yet despite decades of research on this process in open-ocean and temperate waters, tropical estuaries have been largely overlooked. The Cochin Estuary (CE) in Kerala, southwest India, is one of the most biologically productive and heavily used coastal waterways in the country — fed by six major rivers, shaped by the monsoon, and bordered by industrial activity. A research team led by Dr. Dibu Divakaran and Dr. Doniya Elze Mathew, from the Department of Chemical Oceanography, Cochin University of Science and Technology (CUSAT), Kochi, India, set out to fill this knowledge gap by conducting the first-ever study of DMSP concentrations and the bacteria that degrade it along the entire length of the Cochin Estuary.
What the Team Measured, Collected, and Found
Between 2015 and 2018, the researchers sampled water and sediment at fifteen stations spread across the upper, middle, and lower sections of the estuary — covering three distinct seasons: pre-monsoon, monsoon, and post-monsoon. DMSP and DMS levels were measured using gas chromatography, and bacterial communities were cultured, counted, and identified using 16S rRNA gene sequencing. The picture that emerged was clear: the estuary's sediments, not the overlying water, are where most of the microbial action takes place. DMSP concentrations in the sediment were consistently higher than in the water column, and the sediment harboured roughly twice as many bacteria per gram as the water held per millilitre. The highest DMSP levels were recorded at station S7 in the middle estuary (Thevara) during the pre-monsoon season, when salinity and temperature were at their peak — conditions that strongly correlate with increased phytoplankton DMSP production. Four bacterial strains capable of growing on DMSP as their sole carbon source were isolated, all from sediment: two members of the γ-Proteobacteria group (Acinetobacter calcoaceticus and Acinetobacter beijerinckii) and two from the Firmicutes group (Bacillus cereus and Lysinibacillus fusiformis). Crucially, A. calcoaceticus was found to carry the dddP gene — a gene that codes for the enzyme directly responsible for splitting DMSP into DMS — confirming that active enzymatic release of the climate gas is occurring within this estuary's sediments.
What These Findings Mean for Science and Beyond
This study is the first to establish a baseline for DMSP dynamics and DMSP-degrading bacteria in the Cochin Estuary, and its findings carry significance well beyond Kerala. By confirming that estuarine sediments in tropical India serve as active sites for sulfur cycling — and by identifying the specific bacteria driving that process — the research fills a genuine blank in the global map of marine sulfur flux. The monsoon-driven swings in salinity and temperature were found to directly shape which bacteria thrive and how active they are, underscoring how sensitive this process is to seasonal and, by extension, longer-term climatic changes. The authors also highlight a practical dimension: bacteria like A. calcoaceticus and B. cereus, with their demonstrated ability to break down organosulfur compounds, could in the future be used in bioengineering applications to manage sulfur emissions or treat volatile sulfur pollutants in aquatic environments. The researchers call for follow-up studies using metagenomics and metatranscriptomics to map the full range of DMSP-degrading pathways operating in this estuary across more stations and seasons — work that will ultimately sharpen our ability to model how coastal ecosystems influence the atmosphere and, through it, the climate.
About the Study Divakaran D, Sujatha C.H, Mathew D.E. Dimethylsulfoniopropionate (DMSP) Degradation by Marine Bacteria along the Cochin Estuarine System. Open Biotechnol. J., 2026; 20: e18740707433988.
